Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia

Farhat L. Khanim, Rachel E. Hayden, Jane Birtwistle et al. · 2009

Read Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia by Farhat L. Khanim, Rachel E. Hayden, Jane Birtwistle et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008147.txt.

Description

Farhat Khanim and colleagues paired two old drugs against a hard leukemia in PLOS ONE in 2009. Acute myeloid leukemia strikes mostly people over sixty, and standard care fails many of them. The pair joined a cholesterol drug, bezafibrate, with a hormone drug used for other ills.

Together, the two pushed leukemia cells to mature and die in ways neither did alone. Two cheap, well-known drugs with a fresh use would be a gift to older patients who cannot bear harsh chemotherapy. The lab results earned the pair a closer look in trials.

Catalog record

CREATORFarhat L. Khanim, Rachel E. Hayden, Jane Birtwistle et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008147

Browse the full library · About the Tower of Babel